Simulations Plus, Inc. Share Price Today: Live Updates & Key Insights

Simulations Plus, Inc. share price today is $11.75, up -0.34%. The stock opened at $11.59 against the previous close of $11.71, with an intraday high of $11.665 and low of $11.4122.

Simulations Plus, Inc. Share Price Chart

Simulations Plus, Inc.

us-stock
To Invest in {{usstockname}}
us-stock

Simulations Plus, Inc. Share Price Performance

$11.75 -0.0034(-0.34%) SLP at 23 Mar 2026 03:14 PM Health Information Services
Lowest Today 11.4122
Highest Today 11.665
Today’s Open 11.59
Prev. Close 11.71
52 Week High 36.45
52 Week Low 11.16
Day’s Range: Low 11.4122 High 11.665
52-Week Range: Low 11.16 High 36.45
1 day return -
1 Week return -3.79
1 month return +2.09
3 month return -39.59
6 month return -22.76
1 year return -54.43
3 year return -73.18
5 year return -81.66
10 year return -

Simulations Plus, Inc. Institutional Holdings

First Light Asset Management, LLC 9.77

Morgan Stanley - Brokerage Accounts 6.44

BlackRock Inc 6.08

Vanguard Group Inc 5.02

Ameriprise Financial Inc 3.59

Marshall Wace Asset Management Ltd 2.83

Tributary Capital Management, LLC 2.82

Rockefeller Capital Management L.P. 2.77

Vanguard Total Stock Mkt Idx Inv 2.67

Stephens Inv Mgmt Group LLC 2.55

Stephens Small Cap Growth 2.54

Arnhold & S. Bleichroeder Advisers, LLC 2.27

Tributary Small Cap Equity 2.18

First Eagle Small Cap Opportunity I 2.09

iShares Russell 2000 ETF 2.00

Royce & Associates, LP 2.00

First Eagle US Small Cap Strategy 1.99

Geode Capital Management, LLC 1.98

Kennedy Capital Management Inc 1.98

State Street Corp 1.98

Bank of America Corp 1.83

Dimensional Fund Advisors, Inc. 1.73

Meros Investment Management, LP 1.68

JPMorgan Chase & Co 1.66

Sio Capital Management, LLC 1.59

Kennedy Small Cap Value 1.56

Tributary Small Company Instl 1.55

Citadel Advisors Llc 1.38

Nicholas Small-Cap Growth Equity 1.29

Royce Micro-Cap Trust 1.21

Herald Ord 0.99

Rockefeller US Sm Cp Eq Impr F USDAccUnh 0.92

Vanguard Institutional Extnd Mkt Idx Tr 0.91

Fidelity Small Cap Index 0.81

iShares Russell 2000 Growth ETF 0.70

American Beacon Stephens Sm Cp Gr Inv 0.68

Royce Micro-Cap Invmt 0.60

North Star Micro Cap I 0.57

State St Russell Sm/Mid Cp® Indx SL Cl I 0.51

Small Cap Value / Kennedy SP 0.50

Simulations Plus, Inc. Market Status

Strong Buy: 5

Buy: 0

Hold: 1

Sell: 0

Strong Sell: 0

Simulations Plus, Inc. Fundamentals

Market Cap 235.11 M

PB Ratio 1.8488

PE Ratio 0.0

Enterprise Value 199.88 M

Total Assets 131.94 M

Volume 206401

Simulations Plus, Inc. Company Financials

Annual Revenue FY25:79179000 79.2M, FY24:70013000 70.0M, FY23:59577000 59.6M, FY22:53906000 53.9M, FY21:46466000 46.5M

Annual Profit FY25:46221000 46.2M, FY24:43151000 43.2M, FY23:47947000 47.9M, FY22:43084000 43.1M, FY21:35866000 35.9M

Annual Net worth FY25:-64718000 -64.7M, FY24:9954000 10.0M, FY23:9961000 10.0M, FY22:12483000 12.5M, FY21:9782000 9.8M

Quarterly Revenue Q4/2025:18421000 18.4M, Q3/2025:17460000 17.5M, Q2/2025:20363000 20.4M, Q1/2025:22432000 22.4M, Q4/2024:18924000 18.9M

Quarterly Profit Q4/2025:10891000 10.9M, Q3/2025:9844000 9.8M, Q2/2025:13032000 13.0M, Q1/2025:13127000 13.1M, Q4/2024:10218000 10.2M

Quarterly Net worth Q4/2025:676000 0.7M, Q3/2025:-681000 -0.7M, Q2/2025:-67317000 -67.3M, Q1/2025:3074000 3.1M, Q4/2024:206000 0.2M

About Simulations Plus, Inc. & investment objective

Company Information Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through Software and Services segments. The company offers GastroPlus, which predicts absorption, biopharmaceutics, pharmacokinetics, and pharmacodynamics in humans and animals; and DDDPlus and MembranePlus simulation products. It also provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, OBESITYsym, and Thales products. In addition, the company offers Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Further, it provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Additionally, the company offers creative and insightful consulting services to support its quantitative systems pharmacology and other modeling systems. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Research Triangle Park, North Carolina.

Organisation Health Information Services

Employees 212

Industry Health Information Services

CEO null

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Simulations Plus, Inc. FAQs

What is the share price of Simulations Plus, Inc. today?

The current share price of Simulations Plus, Inc. is $11.75.

Can I buy Simulations Plus, Inc. shares in India?

Yes, Indian investors can buy Simulations Plus, Inc. shares by opening an international trading and demat account with Motilal Oswal.

How to buy Simulations Plus, Inc. shares in India?

You can easily invest in Simulations Plus, Inc. shares from India by:

Can I buy fractional shares of Simulations Plus, Inc.?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Simulations Plus, Inc.?

Simulations Plus, Inc. has a market cap of $235.11 M.

In which sector does Simulations Plus, Inc. belong?

Simulations Plus, Inc. operates in the Health Information Services sector.

What documents are required to invest in Simulations Plus, Inc. stocks?

To invest, you typically need:

What is the PE and PB ratio of Simulations Plus, Inc.?

The PE ratio of Simulations Plus, Inc. is N/A and the PB ratio is 1.85.